Characterization of the optimized nanoparticles (These values are means of a minimum of 5 batches). by Anjuman Arora (750291)

Subjects:

The ratio of standard deviation to mean dose (SD/mean) decreases with neuronal dose. by Murat Alp (781371)

PRV-induced infertility is caused by decreased P4 level. by Bing-Qian Su (8616981)

Decrease of TMRE products after 6 h and 12 h of blue light irradiation in OS. by Cora Roehlecke (178080)

“…<p>Images of the outer segment layer of whole mounts stained with 20 nM TMRE after 6 h (<b>A</b>, <b>B</b>) and 12 h cultivation (<b>C</b>, <b>D</b>). …”

Mean-difference plots by country: Countries with decreased variance and decreased mean height (95% confidence interval shaded). by Jewel Gausman (5210969)

Bcl6 deficiency decreases expression of Chrebp in liver. by Christopher R. LaPensee (571785)

“…Bars show the mean+SE for 4 Bcl6 KO and 4 WT mice. Significant decreases in Bcl6 KO relative to WT are designated by * (p<0.05) and ** (p<0.005).…”

WNT3 decreases GCP proliferation by inhibiting SHH dependent gene transcription. by Sandrine L. Anne (489755)

“…(<i>B</i>) WNT3 did not increase cell death of GCPs in a TUNEL assay at 2 DIV (Con, 12.5±1.6%; WNT3, 13.1±0.7% (n=3)). (<i>C</i>) WNT3 decreased SHH dependent proliferation of GCPs (Con & SHH, 354.8±18.7%; WNT3 & SHH, 232.9±28.7% (n=3)). …”

Decreased Drp1 protein expression and Drp1-dependent mitochondrial fission. by Kelly Jean Thomas (134283)

Survival is prolonged when the G59S mutant dynactin is placed on the B6 background and decreased when it is placed on the B6 background compared to the original mixed background (B6/SJL). by Terry D. Heiman-Patterson (580597)

“…<p>Survival is prolonged when the G59S mutant dynactin is placed on the B6 background and decreased when it is placed on the B6 background compared to the original mixed background (B6/SJL).…”

Flowchart of study patients evaluated for cumulative incidence of decreased GFR estimation. by Camila de Souza dos Santos (17721066)

Kalirin-7 decreases synphilin-1-induced aggregates in biochemical and live cell analysis. by Yu-Chun Tsai (110682)

Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

Summary of the gradual disappearance of the peaks with decreasing DMSO-d6 concentrations. by Swagata Chakraborty (188090)

Subjects:

Bcl6 deficiency decreases expression of lipogenic genes and proteins in liver. by Christopher R. LaPensee (571785)

Bcl6 deficiency decreases accumulation of liver triglycerides during fasting. by Christopher R. LaPensee (571785)

Summary of predictors that increase (+ UC) and decrease (- UC) the dose of propofol for the three statistical models used for data analysis. by Chiara E. Hampton (16484687)

Subjects:

Transcriptional repression of synapse-related genes and a decrease in spine density by AAV-hGATA1 and AAV-hGATA2 in DG of the rat hippocampus. by Miyeon Choi (648726)

“…(g) Representative images are shown of high-magnification Z-stack projections of apical tuft segments of GFP(+) DG granule cells from AAV-ctl, AAV-hGATA1 and AAV-hGATA2-injected rats. (h) Density of dendritic spines (arrowheads) was significantly decreased in AAV-hGATA1- and AAV-hGATA2-injected rats compared with AAV-ctl-injected rats (a main effect of virus, <i>F</i>_2,13 = 12.9, <i>P</i><0.0001; AAV-hGATA1: <i>F</i>_1,10 = 21.15, <i>P</i> = 0.0009; AAV-hGATA2: <i>F</i>_1,7 = 5.63, <i>P</i> = 0.04). …”

<i>In-vitro</i> drug release profiles of (a) amlodipine, (b) hydrochlorothiazide, and (c) candesartan. by Anjuman Arora (750291)

Subjects:

FT-IR spectra of (a) amlodipine (b) hydrochlorohiazide and (c) candesartan nanoparticles. by Anjuman Arora (750291)

Subjects:

PK profiles of the developed nanoparticles vs. free drugs in rats (a) amlodipine, (b) hydrochlorothiazide, and (c) candesartan. by Anjuman Arora (750291)

Subjects: